These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33356314)

  • 1. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma.
    Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh S; Singh P; Guleria A; Saha S; Saraf SA
    Mol Pharm; 2021 Mar; 18(3):1102-1120. PubMed ID: 33356314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.
    Wei M; Guo X; Tu L; Zou Q; Li Q; Tang C; Chen B; Xu Y; Wu C
    Int J Nanomedicine; 2015; 10():5123-37. PubMed ID: 26316745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma.
    Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh P; Tabassum H; Alka ; Singh S; Guleria A; Saraf SA
    Int J Pharm; 2022 Jun; 622():121848. PubMed ID: 35613653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
    Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
    Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactic-
    Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
    Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
    Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
    Wei MY; Zou Q; Wu CB; Xu YH
    Yao Xue Xue Bao; 2015 Oct; 50(10):1272-9. PubMed ID: 26837173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
    Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
    Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
    Wei M; Xu Y; Zou Q; Tu L; Tang C; Xu T; Deng L; Wu C
    Eur J Pharm Sci; 2012 Jun; 46(3):131-41. PubMed ID: 22369856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.
    Jain S; Bhankur N; Swarnakar NK; Thanki K
    Pharm Res; 2015 Oct; 32(10):3282-92. PubMed ID: 25968624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.
    Thapa RK; Choi JY; Poudel BK; Hiep TT; Pathak S; Gupta B; Choi HG; Yong CS; Kim JO
    ACS Appl Mater Interfaces; 2015 Sep; 7(36):20360-8. PubMed ID: 26315487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.
    Kumar V; Bhatt PC; Rahman M; Kaithwas G; Choudhry H; Al-Abbasi FA; Anwar F; Verma A
    Int J Nanomedicine; 2017; 12():6747-6758. PubMed ID: 28932118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
    Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L
    Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy.
    Mokhtar S; Khattab SN; Elkhodairy KA; Teleb M; Bekhit AA; Elzoghby AO; Sallam MA
    Front Chem; 2022; 10():847573. PubMed ID: 35392419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management.
    Freag MS; Torky AS; Nasra MM; Abdelmonsif DA; Abdallah OY
    Nanomedicine (Lond); 2019 Apr; 14(8):931-954. PubMed ID: 30925102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
    Elgindy NA; Mehanna MM; Mohyeldin SM
    Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.